Showing results (591-600 of 7,296) with videos related to
Sort By:
Pageof 730
Cell Cycle (Georgetown, Tex.)|August 3, 2010
Ionizing radiation and hematopoietic malignancies: altering the adaptive landscapeCourtney J Fleenor, Andriy Marusyk, James DeGregoriCell Cycle (Georgetown, Tex.)|August 3, 2010
MAD2 downregulation in hypoxia is independent of promoter hypermethylationMaria Prencipe, Aloysius McGoldrick, Antoinette S Perry, et al.Cell Cycle (Georgetown, Tex.)|August 21, 2010
The fate of metaphase kinetochores is weighed in the balance of SUMOylation during S phaseDebaditya Mukhopadhyay, Mary DassoCell Cycle (Georgetown, Tex.)|June 10, 2011
Azacitidine-resistant SKM1 myeloid cells are defective for AZA-induced mitochondrial apoptosis and autophagyThomas Cluzeau, Guillaume Robert, Alexandre Puissant, et al.Cell Cycle (Georgetown, Tex.)|June 10, 2011
From Plk1 to Plk5: functional evolution of polo-like kinasesGuillermo de Cárcer, Gerard Manning, Marcos MalumbresCell Cycle (Georgetown, Tex.)|June 10, 2011
Requirement of evading apoptosis for HIF-1α-induced malignant progression in mouse cellsMasami Hayashi, Yoo Young-Gun Yoo, Jared Christensen, et al.Cell Cycle (Georgetown, Tex.)|June 14, 2011
Is carcinogenesis a form of speciation?Peter Duesberg, Daniele Mandrioli, Amanda McCormack, et al.Cell Cycle (Georgetown, Tex.)|June 15, 2011
Caveolin-2-deficient mice show increased sensitivity to endotoxemiaCecilia J de Almeida, Agnieszka K Witkiewicz, Jean-François Jasmin, et al.Cell Cycle (Georgetown, Tex.)|June 15, 2011
Chromium induces chromosomal instability, which is partly due to deregulation of BubR1 and Emi1, two APC/C inhibitorsLiyan Hu, Xin Liu, Yana Chervona, et al.Cell Cycle (Georgetown, Tex.)|June 15, 2011
mTOR complex 2 signaling and functionsWon Jun Oh, Estela JacintoPageof 730